Get the Stockscreener App
1.53
2.00%
0.03
After Hours:
1.49
-0.04
-2.61%
Pmv Pharmaceuticals Inc stock is traded at $1.53, with a volume of 631.09K.
It is up +2.00% in the last 24 hours and up +50.00% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.50
Open:
$1.51
24h Volume:
631.09K
Relative Volume:
1.22
Market Cap:
$81.41M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.53
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
+11.68%
1M Performance:
+50.00%
6M Performance:
+4.79%
1Y Performance:
+11.68%
1-Day Range:
$1.48
$1.57
1-Week Range:
$1.30
$1.88
52-Week Range:
$0.81
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.53 | 79.82M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
PMVP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Short Interest Update - MarketBeat
PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Health Rounds: Researchers find cellular clues to explain faster pain recovery in men - marketscreener.com
PMV Pharma’s rezatapopt study published in New England Journal - Investing.com Australia
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
PMV Pharmaceuticals (PMVP) Publishes Positive Phase 1 Results fo - GuruFocus
PMV Pharma’s rezatapopt study published in New England Journal By Investing.com - Investing.com UK
New England Journal of Medicine Publishes First-in-Human - GlobeNewswire
Risk Analysis: Is PMV Pharmaceuticals Inc benefiting from interest rate changes2025 Biggest Moves & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Monday - Defense World
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
Decliners Report: Can NSYS lead its sector in growthTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Signal Recap: How much upside does LNKB haveJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Dow Update: Is Oxbridge Re Holdings Limited benefiting from interest rate changes2025 Geopolitical Influence & Short-Term High Return Ideas - baoquankhu1.vn
Growth Review: Is Accretion Acquisition Corp Equity Right stock risky to hold nowMarket Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Will PMV Pharmaceuticals Inc outperform its industry peersJuly 2025 WrapUp & Weekly Market Pulse Alerts - baoquankhu1.vn
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 0.9%Time to Buy? - MarketBeat
Fund Flows: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Sentiment Report & Fast Gaining Stock Reports - baoquankhu1.vn
Why Columbus Acquisition Corp stock is a value investor pickRate Cut & Weekly Watchlist of Top Performers - mfd.ru
Will NDLS stock deliver better than expected guidanceWeekly Trend Report & Weekly Stock Breakout Alerts - mfd.ru
PMVP PE Ratio & Valuation, Is PMVP Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and OrganiGram Holdings (OGI) - The Globe and Mail
Guidance Update: Is PMV Pharmaceuticals Incs ROE strong enoughJuly 2025 PreEarnings & Weekly Stock Breakout Alerts - baoquankhu1.vn
Fed Watch: Will PMV Pharmaceuticals Inc outperform its industry peersAnalyst Upgrade & AI Powered Market Entry Strategies - baoquankhu1.vn
PMV Pharmaceuticals: Key Catalysts Approach in Q1 2026 - AD HOC NEWS
Tech Rally: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Volume Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Support Test: Whats the outlook for PMV Pharmaceuticals Incs sectorProduct Launch & Detailed Earnings Play Alerts - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Xeris Pharmaceuticals (XERS) - The Globe and Mail
Caesarstone And 2 More Penny Stocks Worth Watching - simplywall.st
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4% – Here’s Why - Defense World
Weekly Earnings: Can MTRX generate free cash flowQuarterly Trade Summary & Safe Entry Zone Identification - baoquankhu1.vn
Stock Market Recap: Does LEGTWS have strong EBITDA marginsBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
Options Flow: Will Ford Motor Company outperform tech stocksGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
MBX Biosciences appoints Laurie Stelzer to board of directors By Investing.com - Investing.com Nigeria
MBX Biosciences appoints Laurie Stelzer to board of directors - Investing.com
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair - The Manila Times
Laurie Stelzer, ex-CFO at Mirati and Arena, joins MBX board - Stock Titan
Aug EndMonth: Will IMXI benefit from green energy policies2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Stock Recap: Is PMV Pharmaceuticals Inc a strong candidate for buy and hold2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Take Profit: How does OPRT correlate with NasdaqJuly 2025 Catalysts & Accurate Intraday Trade Tips - baoquankhu1.vn
How FLYX.W stock compares with market leadersMarket Performance Summary & Stepwise Swing Trade Plans - bollywoodhelpline.com
Why analysts upgrade PMV Pharmaceuticals Inc. stockJuly 2025 Trends & Long-Term Growth Stock Strategies - bollywoodhelpline.com
Will PMV Pharmaceuticals Inc. outperform its industry peersJuly 2025 Volume & Low Drawdown Investment Strategies - bollywoodhelpline.com
Trading Recap: Can VALWS stock outperform in a bear marketJuly 2025 Technicals & Technical Buy Zone Confirmation - baoquankhu1.vn
Fed Watch: Can PMV Pharmaceuticals Inc grow without external funding2025 Sector Review & Reliable Price Breakout Signals - baoquankhu1.vn
Growth Report: Can PMV Pharmaceuticals Inc. stock double in next 5 yearsWeekly Investment Report & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Fed Meeting: How PMV Pharmaceuticals Inc stock reacts to oil pricesJuly 2025 Summary & Risk Managed Trade Strategies - Bộ Nội Vụ
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature
Can Cranex Limited Overcome Bearish SentimentMarket Profile Overview & Big Profit Small Budget - bollywoodhelpline.com
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):